Activest Wealth Management Viking Therapeutics, Inc. Transaction History
Activest Wealth Management
- $347 Million
- Q1 2025
A detailed history of Activest Wealth Management transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Activest Wealth Management holds 1,608 shares of VKTX stock, worth $41,679. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,608
Previous 2,165
25.73%
Holding current value
$41,679
Previous $87,000
56.32%
% of portfolio
0.01%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
434Shares Held
65.3MCall Options Held
8.28MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$263 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$156 Million0.01% of portfolio
-
State Street Corp Boston, MA4.06MShares$105 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$81 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$80.9 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.99B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...